Urolog. pro Praxi, 2007; 8(5): 195
Urolog. pro Praxi, 2007; 8(5): 202-204
In recent years, the subject field of individual specialities has narrowed down. The sphere of interest as well as actual care sometimes overlap with the care originally provided exclusively by another discipline. A specific status is ascribed to oncology which is a blending of three disciplines: internal medicine, surgery, and radiology. Nonetheless, a recent Ministry of Health order attributes a dominant position to clinical oncologists. In this new context, a definition of the urologist‘s position is being sought who can both historically and currently diagnose and treat some urooncologic diseases and who would be supposed to continue in this...
Urolog. pro Praxi, 2007; 8(5): 205-210
Urinary tract infections are a common problem for a clinical urologists. The infections are generally caused by common fecal bakteria (mainly Enterobacteriaceae) but the incidence of an intracellular STD (sexually transmitted diseases) pathogens have also significantly increased. Among most common bacterial STD pathogens diagnosis for patient visits to physician office nowadays are Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis and Mycoplasma genitalium. Patient may complain only of urethral itch, urethral discharge or clinical symptoms could include dysuria, frequency, urgency, voiding of small urine volumes, and epididymitis. Asymptomatic...
Urolog. pro Praxi, 2007; 8(5): 211-216
Overactive bladder is not malignant disease, but from the point of view of patients complaints and quality of life it is very serious problem.This state of the art article inform about some news in diagnostics and treatment patients with OAB.
Urolog. pro Praxi, 2007; 8(5): 218-221
The NCCN (National Comprehensive Cancer Network) practice guidelines in oncology, in its 2nd version in 2007, slightly changed its recommendations for the treatment of prostate cancer. Some of these changes, which concerns combination external beam radiotherapy and androgen deprivation therapy in prostate cancer, are making both guidelines, European and American ones, almost identical. According to these guidelines, external beam radiotherapy in combination with androgen deprivation therapy in patients with T2c-T4 N0/1 M0 can reduce risk of biochemical and clinical progression. Further more, this combination therapy can improve overall survival...
Urolog. pro Praxi, 2007; 8(5): 223-228
Benign prostatic hyperplasia (BPH) together with a cataract is the most common non-malignant male diseases that are manager by an invasive procedure. The incidence is not obvious unequivocally due to the existence of different forms of the disease (histologic, asymptomatic – compensated obstruction, symptomatic). It is generally acceptable, that nearly 40 % of men in their forties are affected by some lower urinary tract symptoms. Because there are additional diseases of both sexes (and logically there is no prostate in women) that can cause identical symptoms the term lower urinary tract symptoms (LUTS) was introduced. In case of prostatic...
Urolog. pro Praxi, 2007; 8(5): 230-232
Incontinence diagnostics and therapy of an old patient with a restricted mobility is more difficult to be processed and therefore inadequate many times. A suitable assessing technique is described in the following article.
Urolog. pro Praxi, 2007; 8(5): 234-239
Paper makes a brief summary of relevant information concerning combination pharmacotherapy in men with lower urinary tract symptoms (LUTS) and informs about indications, effectiveness, adverse effects of various types of combination pharmacological treatment. Diagnosis and therapy of LUTS must be comprehensive and individualized. Combination therapy of an alpha-blocker with a 5alpha-reductase-inhibitor seems to be more beneficial and durable than the monotherapy of either substance in symptomatic men with high risk of progression of benign prostate hyperplasia. Indications for using of combination alpha-blocker + 5alpha-reductase-inhibitor are: symptomatic...
Urolog. pro Praxi, 2007; 8(5): 243-244
Urolog. pro Praxi, 2007; 8(5): 241-242
Urolog. pro Praxi, 2007; 8(5): 245-246
Urolog. pro Praxi, 2007; 8(5): 248-249
Urolog. pro Praxi, 2007; 8(5): 250